Skip to main content
Equibles

GSK · GSK plc

Use GSK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GSK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
17.5900 GBP -0.2050 (-1.15%) At close · Oct 5
Rebalance outlook locked

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close17.5900 GBP Open17.8650 GBP Day17.5500–17.9000 GBP 52W close16.1450–22.6800 GBP Avg vol 30d5.8M Last earningsFeb 3, 2027 DataJul 2022–Oct 2026

Raw chart and full-history price indicators begin at the captured split on Jul 19, 2022; bars on opposite sides are not compared.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 16.1450 GBP Now 17.5900 GBP · 22% Range high 22.6800 GBP
vs 200-day avg -10% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jul 19, 2022; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XLON:GSK -5.4% -4.3% -17.5% -4.0% -3.6%

Exchange listing

Market
XLON
Ticker
GSK
ISIN
GB00BN7SWP63
Security
—
Trading currency
GBP

Company with tickers: GSK, GLAXF

Company

Website
https://www.gsk.com/
Investor relations
https://www.gsk.com/en-gb/company/governance/shareholders/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

DateEventType
2026-10-28 00:00 UTC We will announce our third quarter results on Wednesday, 28 October 2026. Results publication
2027-02-03 00:00 UTC We will announce our full year and fourth quarter results on Wednesday, 3 February 2027. Results publication

Earnings calls

  • Earnings call · Q4 2026 2027-02-03 Scheduled
    We will announce our full year and fourth quarter results on Wednesday, 3 February 2027.
  • Earnings call · Q3 2026 2026-10-28 Scheduled
    We will announce our third quarter results on Wednesday, 28 October 2026.
  • Conference · September 2026 2026-09-23 Audio Transcript
    Julie Brown, Chief Financial Officer, will attend and take part in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 23 September 2026.
  • Conference · September 2026 2026-09-09 Audio Transcript
    Julie Brown, Chief Financial Officer, will attended and take part in a fireside chat at the Bernstein’s 23rd Annual Pan-European Strategic Decisions Conference in London on Wednesday, 9 September 2026.
  • Conference · September 2026 2026-09-09 Audio Transcript
    Julie Brown, Chief Financial Officer, will attend and take part in a fireside chat at the Bernstein’s 23rd Annual Pan-European Strategic Decisions Conference in London on Wednesday, 9 September 2026.
  • Earnings call · Q2 2026 2026-07-28
    Earnings conference call (announced in 6-K)
  • Earnings call · Q1 2026 2026-04-29 Transcript
    GSK plc Q1 FY2026 Earnings Call